Description: Enovis Corporation is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond.
Home Page: www.enovis.com
ENOV Technical Analysis
2711 Centerville Road
Wilmington,
DE
19808
United States
Phone:
302 252 9190
Officers
| Name | Title |
|---|---|
| Mr. Mitchell P. Rales | Co-Founder & Independent Chairman |
| Mr. Matthew L. Trerotola | CEO & Director |
| Mr. Brady R. Shirley | Pres, COO & Director |
| Mr. Christopher M. Hix | Exec. VP of Fin. & CFO |
| Mr. Daniel A. Pryor | Exec. VP of Strategy & Bus. Devel. |
| Mr. John Kleckner | Principal Accounting Officer |
| Mr. Michael S. Macek | VP of Fin. & Investor Relations |
| Mr. Bradley J. Tandy | Sr. VP & Gen. Counsel |
| Katie Sweet | VP of Corp. Communication |
| Ms. Patricia A. Lang | Sr. VP & Chief HR Officer |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 22.0264 |
|---|---|
| Trailing PE: | 15.1163 |
| Price-to-Book MRQ: | 0.878 |
| Price-to-Sales TTM: | 0.7335 |
| IPO Date: | 2008-05-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 16200 |